Applications of microRNAs in the diagnosis and prognosis of lung cancer
- 18 March 2012
- journal article
- Published by Informa Healthcare in Expert Opinion on Medical Diagnostics
- Vol. 6 (3), 197-207
- https://doi.org/10.1517/17530059.2012.672970
Abstract
Introduction: Lung cancer is the leading cause of cancer death worldwide, due to its late diagnosis and poor outcome. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional levels by either degrading or blocking translation of messenger RNA targets. Accumulating evidence indicates that miRNAs play a pivotal role in the development and progression of human malignancies, including lung cancer. Areas covered: In this review, the authors focus on i) application of miRNA-based biomarkers to help classify lung cancer, ii) application of the miRNA biomarkers for the early detection of lung cancer and iii) use of miRNAs as biomarkers to predict outcomes of lung cancer. Expert opinion: miRNAs provide promising biomarkers for the diagnosis and prognosis of lung cancer. The developed miRNA biomarkers should be comprehensively and prospectively validated in clinical trials before being used in laboratory settings.Keywords
This publication has 68 references indexed in Scilit:
- A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancerEMBO Molecular Medicine, 2011
- Circulating miRNA signature for early diagnosis of lung cancerEMBO Molecular Medicine, 2011
- Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancerInternational Journal of Cancer, 2011
- Plasma microRNAs as potential biomarkers for non-small-cell lung cancerLaboratory Investigation, 2011
- Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancerMolecular Oncology, 2011
- MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migrationInternational Journal of Cancer, 2011
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markersInternational Journal of Cancer, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- MicroRNA expression profiles classify human cancersNature, 2005